Global Human Microbiome Market: Overview
The enormous amount of microorganisms that survive in and on the human body are referred as human microbiome. The microorganisms may include fungi, bacteria, and protozoa. According to the researches and studies, scientists have suggested that these microorganisms play an important role in maintaining the digestive system, vitamin synthesis, immune system, and neurological system. The human microbiome is expected to gain a significant position in the global market in the coming years due to the rise in the awareness about its benefits. The therapies that are based on human microbiome are available in the form of prebiotics, probiotics, drugs, foods, diagnostic devices, medical foods, and supplements
Global Human Microbiome Market: Segmentation
The human microbiome market is globally segmented into its product, application, and disease. On the basis of product, the global market is segregated into prebiotics, medical foods, drugs, probiotics, food, devices, and other probiotic supplements. Based on the application, the market is categorized into diagnostics and therapeutics. Depending on the diseases, the human microbiome market is divided into obesity, autoimmune disorders, acute diarrhea, cardiovascular disorders, drug metabolism, diabetes, cancer, metabolic syndrome, and atopic dermatitis.
Global Human Microbiome Market: Growth Factors
The factors that are attributing to the market growth are autoimmune disorders, the rise in the chronic diseases, such as diabetes, obesity, and cancer, and expanding the base of patients suffering from lifestyle diseases. The consumers are more preferring for therapies that are based on human microbiome thus triggering the growth of the market. The therapy is increasingly used in early detection of the diseases and the development and diagnosis of the drugs. The growing geriatric population and the increasing advancements in the field of life science are augmenting the market growth. There are certain factors that hamper the market growth which includes lack of technical knowledge and the deficiency of comprehensive research.
Global Human Microbiome Market: Regional Analysis
The regions that are dominating and are going to dominate the human microbiome market are Europe and the North America. The factors that attribute to this growth are the increasing base of the aging population, increasing cases of the lifestyle diseases, and the occurrences of the autoimmune disorders. The factors such as growing microbiological research infrastructure and the presence of advanced biotechnological treatments are influencing the probiotics and prebiotics. The countries that are leading the market by contributing major revenue are the US from the North American region and Spain, Germany, and France from Europe. Asia Pacific region also has a promising future in the market owing to the rise in the investments that are made by the private organizations and governments for the development of the field. The factor that the research infrastructure is developing in the emerging economies has given a significant boost to the market growth.
Global Human Microbiome Market: Competitive Players
Some of the major companies in the human microbiome market include Merck, DuPont, MicroBiome Therapeutics LLC, Osel, Metabiomics Corporation, Enterome Bioscience, Yakult, ViThera Pharmaceuticals, and Vedanta BioSciences.
Global Human Microbiome Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
